Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

ACHC


Top 10 Correlated ETFs

ACHC


Top 10 Correlated Stocks

ACHC


In the News

12:02 04 Oct 2022 ACHC

Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit

Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.

03:46 04 Oct 2022 ACHC

Stocks At New Highs: Fertilizer Maker, Mental Health Provider Hit Buy Points

Few stocks hit 52-week highs amid a big market sell-off to end the week. Two stocks at new highs are industry leaders, allowing their stocks to rise with them.

11:18 04 Oct 2022 ACHC

Acadia Healthcare (ACHC) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

12:02 04 Oct 2022 ACHC

Acadia Healthcare (ACHC) Stock Up 3% on Q2 Earnings Beat

Acadia Healthcare's (ACHC) second-quarter results benefit from a strong-performing U.S. business. A raised 2022 guidance with respect to EPS bodes well.

11:18 04 Oct 2022 ACHC

Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?

Here is how Acadia Healthcare (ACHC) and AxoGen (AXGN) have performed compared to their sector so far this year.

12:52 04 Oct 2022 ACHC

Acadia Healthcare Company, Inc. (ACHC) CEO Christopher Hunter on Q2 2022 Results - Earnings Call Transcript

Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Christopher Hunter - Chief Executive Officer and Director David Duckworth - Chief Financial Officer Gretchen Hommrich - Vice President, Investor Relations Conference Call Participants Andrew Mok - UBS Whit Mayo - SVB Securities Kevin Fischbeck - Bank of America Brian Tanquilut - Jefferies Benjamin Hendrix - RBC Capital Markets A.J. Rice - Credit Suisse John Ransom - Raymond James Matthew Borsch - BMO Capital Markets Sarah James - Barclays Operator Good morning, and welcome to the Acadia Healthcare Second Quarter 2022 Earnings Conference Call.

10:52 04 Oct 2022 ACHC

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?

Here is how Acadia Healthcare (ACHC) and Chinook Therapeutics (KDNY) have performed compared to their sector so far this year.

01:03 04 Oct 2022 ACHC

Acadia Healthcare: Capitalizing On Major Mental Health Trend

Acadia operates a network of mental health and substance abuse treatment facilities. Its business has shown strong resiliency during the COVID-19 pandemic.

11:00 04 Oct 2022 ACHC

Acadia Healthcare Announces Date for Second Quarter 2022 Earnings Release

FRANKLIN, Tenn.--(BUSINESS WIRE)---- $ACHC--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2022 results on Wednesday, July 27, 2022, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, July 28, 2022. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call w

02:40 04 Oct 2022 ACHC

Factors that Make Acadia Healthcare (ACHC) an Attractive Bet Now

Solid demand for behavioral healthcare services, growth-related efforts in the form of JVs, declining debt burden and sufficient cash-generating abilities continue to benefit Acadia Healthcare (ACHC).

Financial details

Company Rating
Strong Buy
Market Cap
7.1B
Income
282.25M
Revenue
2.45B
Book val./share
29.68
Cash/share
1.43
Dividend
-
Dividend %
-
Employees
22.5K
Optionable
No
Shortable
Yes
Earnings
26 Oct 2022
P/E
26.32
Forward P/E
25.44
PEG
-1.87
P/S
2.86
P/B
2.63
P/C
56.57
P/FCF
41.41
Quick Ratio
1.05
Current Ratio
1.17
Debt / Equity
0.56
LT Debt / Equity
0.55
-
-
EPS (TTM)
3.1
EPS next Y
3.18
EPS next Q
0.76
EPS this Y
-128.1%
EPS next Y
2.42%
EPS next 5Y
2.42%
EPS last 5Y
-1.34%
Revenue last 5Y
-3.99%
Revenue Q/Q
5.69%
EPS Q/Q
30.88%
-
-
-
-
SMA20
-4.82%
SMA50
3.95%
SMA100
16.18%
Inst Own
100%
Inst Trans
0.49%
ROA
6%
ROE
11%
ROC
0.1%
Gross Margin
33%
Oper. Margin
18%
Profit Margin
12%
Payout
-
Shs Outstand
90.84M
Shs Float
89.18M
-
-
-
-
Target Price
88
52W Range
50.07-86.75
52W High
-5.93%
52W Low
+61.8%
RSI
44
Rel Volume
0.82
Avg Volume
602.65K
Volume
492.29K
Perf Week
2.38%
Perf Month
-1.77%
Perf Quarter
9.75%
Perf Half Y
20.42%
-
-
-
-
Beta
1.28526
-
-
Volatility
1.5%, 2.48%
Prev Close
3.48%
Price
80.9
Change
1.2%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
32.6234.5135.4723.7826.07
Net income per share
2.3-2.011.24-7.652.2
Operating cash flow per share
4.64.743.87.54.22
Free cash flow per share
1.440.830.555.031.46
Cash per share
0.770.581.424.311.51
Book value per share
29.5926.7328.621.6228.36
Tangible book value per share
-2.8-1.41-0.01-3.1228.31
Share holders equity per share
29.5926.7328.621.6228.36
Interest debt per share
39.2938.7138.4938.8719.63
Market cap
2.98B2.42B2.86B4.45B4.64B
Enterprise value
6.15B5.57B5.92B7.33B6.18B
P/E ratio
14.91-13.7926.25-6.6323.74
Price to sales ratio
1.050.80.922.132.01
POCF ratio
7.455.858.596.7612.41
PFCF ratio
23.7533.3859.2810.0735.88
P/B Ratio
1.161.041.142.341.84
PTB ratio
1.161.041.142.341.84
EV to sales
2.171.851.93.512.67
Enterprise value over EBITDA
11.0631.8112.18-19.3913.82
EV to operating cash flow
15.3913.4417.7811.1316.5
EV to free cash flow
49.0576.66122.7616.5847.72
Earnings yield
0.07-0.070.04-0.150.04
Free cash flow yield
0.040.030.020.10.03
Debt to equity
1.251.351.241.610.63
Debt to assets
0.60.620.630.710.46
Net debt to EBITDA
5.7117.966.3-7.613.43
Current ratio
1.251.081.171.931.22
Interest coverage
2.492.232.162.15.15
Income quality
2-2.363.06-0.981.91
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.640.650.660.080.06
Research and developement to revenue
00000
Intangibles to total assets
0.440.40.370.330.01
Capex to operating cash flow
-0.69-0.82-0.86-0.33-0.65
Capex to revenue
-0.1-0.11-0.09-0.1-0.11
Capex to depreciation
-1.92-2.15-1.74-2.27-2.29
Stock based compensation to revenue
0.010.010.010.010.02
Graham number
39.1234.828.2860.9937.49
ROIC
0.070.070.060.060.09
Return on tangible assets
0.06-0.050.03-0.160.04
Graham Net
-40.13-40.02-44.86-45.47-20.73
Working capital
94.16M34.04M78.64M1.22B90.17M
Tangible asset value
-243.23M-123.29M-956K-274.34M2.51B
Net current asset value
-3.36B-3.36B-3.8B-2.08B-1.69B
Invested capital
1.261.371.271.710.66
Average receivables
328.55M324.57M337.64M297.08M289.21M
Average payables
95.06M102.78M107.43M87.82M93.2M
Average inventory
4.82M4.95M4.81M4.85M0
Days sales outstanding
46.3342.6644.4251.8844.37
Days payables outstanding
326.28360.18376.8225.810
Days of inventory on hand
15.2715.4614.121.430
Receivables turnover
7.888.568.227.038.23
Payables turnover
1.121.010.9714.140
Inventory turnover
23.9123.625.86255.980
ROE
0.08-0.080.04-0.350.08
Capex per share
-3.15-3.91-3.25-2.47-2.76

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
6.556.66.676.917.26
Net income per share
0.50.740.840.680.89
Operating cash flow per share
1.021.241.10.861.66
Free cash flow per share
0.410.750.110.290.75
Cash per share
2.092.211.51.571.43
Book value per share
26.5327.3728.2828.8429.68
Tangible book value per share
2.082.9428.234.195.16
Share holders equity per share
26.5327.3728.2828.8429.68
Interest debt per share
18.1617.4918.8818.4617.47
Market cap
5.57B5.67B5.4B5.85B6.07B
Enterprise value
6.99B7.02B6.94B7.34B7.49B
P/E ratio
31.3121.4517.9624.0418.94
Price to sales ratio
9.589.669.19.499.31
POCF ratio
61.6251.5355.3776.1740.67
PFCF ratio
153.9885.39574.48222.7490.18
P/B Ratio
2.372.332.152.272.28
PTB ratio
2.372.332.152.272.28
EV to sales
1211.9411.6911.911.49
Enterprise value over EBITDA
65.7955.2448.2459.748.8
EV to operating cash flow
77.2163.7371.0695.650.2
EV to free cash flow
192.95105.62737.32279.53111.32
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.010.01000.01
Debt to equity
0.650.620.630.620.56
Debt to assets
0.480.470.460.450.44
Net debt to EBITDA
13.2910.5810.6512.139.27
Current ratio
1.351.411.221.291.17
Interest coverage
6.396.696.256.257.86
Income quality
2.031.671.31.261.86
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.080.080.010.080.08
Research and developement to revenue
00000
Intangibles to total assets
0.480.470.010.470.47
Capex to operating cash flow
-0.6-0.4-0.9-0.66-0.55
Capex to revenue
-0.09-0.07-0.15-0.08-0.13
Capex to depreciation
-2.12-1.57-3.11-1.75-2.81
Stock based compensation to revenue
0.020.020.020.010.01
Graham number
17.2921.3923.1921.0324.41
ROIC
0.030.030.020.020.03
Return on tangible assets
0.020.030.020.020.03
Graham Net
-19.87-19.48-20.67-20.11-19.64
Working capital
150.41M163.87M90.17M119.35M76.38M
Tangible asset value
184.62M261.58M2.51B373.84M463M
Net current asset value
-1.63B-1.59B-1.69B-1.66B-1.63B
Invested capital
0.680.630.660.630.58
Average receivables
337.74M321.03M308.98M336.63M335.65M
Average payables
95.72M95.07M101.39M104.21M107.84M
Average inventory
4.72M4.55M04.77M4.82M
Days sales outstanding
52.3846.7942.6649.1346.22
Days payables outstanding
23.6523.23026.0927.53
Days of inventory on hand
1.271.1701.191.2
Receivables turnover
1.721.922.111.831.95
Payables turnover
3.83.8703.453.27
Inventory turnover
71.1277.02075.3974.89
ROE
0.020.030.030.020.03
Capex per share
-0.61-0.49-0.99-0.57-0.91

Frequently Asked Questions

What is Acadia Healthcare Company, Inc. stock symbol ?

Acadia Healthcare Company, Inc. is a US stock , located in Franklin of Tennessee and trading under the symbol ACHC

Is Acadia Healthcare Company, Inc. buy or a sell ?

10 stock analysts have 10 predictions with a medium analyst target price of $88.4. The lowest prediction is $72 and the highest is $103

What is ACHC stock prediction ?

With a median analyst target price of $91.67, 6 stock analysts have made 6 forecasts in last 90 days. $78 is the lowest and $103 is the greatest projection.

What is Acadia Healthcare Company, Inc. stock quote today ?

Acadia Healthcare Company, Inc. stock price is $80.9 today.

Is Acadia Healthcare Company, Inc. stock public?

Yes, Acadia Healthcare Company, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap